Three Toronto hospitals contract Thinking Systems for PACS services

TriMed Staff | | Health Imaging | Practice Management
The Joint Department of Medical Imaging for University Health Network, Mount Sinai Hospital and Women’s College Hospital of Toronto has purchased ThinkingPACS services from St. Petersburg-based RIS and PACS developer Thinking Systems.

The multi-modality PACS offering will include Thinking Systems’ ModalityBroker, which integrates specialty modalities to the existing enterprise PACS; NuGateway, a DICOM gateway that brings nuclear medicine data from legacy scanners and workstations to PACS; and MDStation, a multi-modality PACS workstation.

The project is a joint venture of Thinking Systems and its exclusive Canadian distributor, ADN Canada.

TriMed Staff

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.